As an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non-HDL-C, and TG levels and to increase HDL-C in crestor side effects patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia.

CRESTOR is contraindicated

In patients with a known hypersensitivity to any component of this product, in patients with active liver disease or crestor side effects with unexplained persistent elevations of serum transaminases, in women who are or may become pregnant, and in nursing mothers. * Risk factors include cigarette smoking, hypertension (blood pressure ?140/90 mm Hg or on antihypertensive medication), HDL-C <40 mg/dL, family history of premature CHD (CHD in male first-degree relative aged <55 years; CHD in female first-degree relative aged <65 years), and crestor side effects age (men aged ?45 years; women aged ?55 years). † According to the third report of the National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III) update, the LDL-C goal is <160 mg/dL for Lower-Risk patients, <130 mg/dL for Moderate-Risk crestor side effects patients, <130 mg/dL (optional goal of <100 mg/dL) for Moderately High-Risk patients, <100 mg/dL for High-Risk patients, and an optional goal of <70 mg/dL for Very High-Risk patients.1,2 ‡ CHD includes previous myocardial infarction, unstable angina, stable angina, angioplasty, bypass surgery, or crestor side effects evidence of clinically significant myocardial ischemia. § CHD risk equivalents include noncoronary forms of atherosclerotic disease (peripheral arterial disease, abdominal aortic aneurysm, carotid artery disease), diabetes, and 2+ risk factors with a 10-year risk for CHD >20%. || crestor side effects Among these risk factors are established CVD plus (1) multiple major risk factors (especially diabetes), (2) severe and poorly controlled risk factors (especially continued cigarette smoking), (3) multiple risk factors of the metabolic syndrome (especially high TG ?200 mg/dL plus non-HDL-C ?130 mg/dL with low HDL-C <40 mg/dL), and (4) patients with acute coronary syndromes.